Synthelis Biotech
PrivateLast Round
Grant
Dec 12, 2024
Total Funding Raised
$830,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Synthelis Biotech is a biotechnology company that provides cell-free protein expression systems and bioluminescence solutions for pharmaceutical, biomedical, and academic research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synthelis Biotech Comparables
Compare Synthelis Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LenioBio | 84% | |
| Tierra Biosciences | 83% | |
| CellFree Sciences Co., Ltd. | 83% |
Synthelis Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 12, 2024 | ||||
| M&A | Nov 24, 2023 | ||||
| Seed | Jan 21, 2014 |
Synthelis Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| France 2030 | Grant |
| Grenoble Angels | Seed |
| Kreaxi | Seed |
| Savoie Mont Blanc Angels | Seed |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 147% MoM, reaching 5.1K.
- Jun 18, 2026
Monthly visitors increased 113% MoM, reaching 2.1K.
Synthelis Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Synthelis Biotech's valuation, stock price, and market status.
Is Synthelis Biotech a public or private company?
Synthelis Biotech is a private company.
What is the current stock price of Synthelis Biotech?
Synthelis Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Synthelis Biotech worth (valuation)?
Valuation information for Synthelis Biotech is not publicly available.
Can I buy Synthelis Biotech stock?
Synthelis Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Synthelis Biotech's last funding round?
Synthelis Biotech's most recent funding round was Grant on December 12, 2024.
Who are the main investors in Synthelis Biotech?
Key investors in Synthelis Biotech include France 2030, Grenoble Angels, Kreaxi, Savoie Mont Blanc Angels, Bpifrance.
Will Synthelis Biotech IPO soon?
No public IPO plans have been announced for Synthelis Biotech.
How can I track Synthelis Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Synthelis Biotech's secondary market activity and sign up for updates.